Inventor
MARTIN MATTHEW W
US73 patents
⚠️ This page may combine multiple inventors who share the name “MARTIN MATTHEW W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA THERAPEUTICS INC
34 patentsUS10112915B2Oct 30, 2018
3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC41 citations99
US10494353B2Dec 3, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10494354B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10472337B2Nov 12, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC17 citations98
US10450284B2Oct 22, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC14 citations98
US10450283B2Oct 22, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC14 citations98
US10442776B2Oct 15, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10428031B2Oct 1, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10421732B2Sep 24, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations98
US10421731B2Sep 24, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC15 citations98
US10414738B2Sep 17, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC16 citations98
US10377726B2Aug 13, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC22 citations98
US10239845B2Mar 26, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC25 citations98
US10214501B2Feb 26, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC20 citations98
US10214500B2Feb 26, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC20 citations98
US10513501B2Dec 24, 2019
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC11 citations93
US10494351B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10494352B2Dec 3, 2019
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10479772B2Nov 19, 2019
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC6 citations93
US10464909B2Nov 5, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10464910B2Nov 5, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10457652B2Oct 29, 2019
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
FORMA THERAPEUTICS INC12 citations93
US10336722B2Jul 2, 2019
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC22 citations93
US9422281B2Aug 23, 2016
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC25 citations93
US9388161B2Jul 12, 2016
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC34 citations93
US10472342B2Nov 12, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC4 citations84
US10399951B2Sep 3, 2019
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC5 citations84
US10266487B2Apr 23, 2019
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC4 citations84
US9745253B2Aug 29, 2017
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
FORMA THERAPEUTICS INC10 citations84
US11111229B2Sep 7, 2021
Tetrahydroquinoline compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC4 citations83
US10611750B2Apr 7, 2020
Tetrahydroquinoline compositions as bet bromodomain inhibitors
FORMA THERAPEUTICS INC7 citations83
US10377769B2Aug 13, 2019
Benzopiperazine compositions as BET bromodomain inhibitors
FORMA THERAPEUTICS INC10 citations83
US10995078B2May 4, 2021
Compounds and compositions for inhibition of FASN
FORMA THERAPEUTICS INC1 citations73
US10508088B2Dec 17, 2019
Methods using HDAC11 inhibitors
FORMA THERAPEUTICS INC3 citations73
VALO HEALTH INC
6 patentsUS11279681B2Mar 22, 2022
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC6 citations94
US12264137B2Apr 1, 2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC0 citations73
US11891365B2Feb 6, 2024
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC1 citations73
US11345672B2May 31, 2022
Methods using HDAC11 inhibitors
VALO HEALTH INC2 citations73
US11274085B2Mar 15, 2022
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC0 citations73
US11274084B2Mar 15, 2022
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO HEALTH INC1 citations73
VALO EARLY DISCOVERY INC
5 patentsUS10829462B2Nov 10, 2020
3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC15 citations98
US10829461B2Nov 10, 2020
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC15 citations98
US10822316B2Nov 3, 2020
3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC10 citations93
US10988450B2Apr 27, 2021
3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
VALO EARLY DISCOVERY INC6 citations92
US10988441B2Apr 27, 2021
Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
VALO EARLY DISCOVERY INC1 citations73
AMGEN INC
4 patentsUS7754717B2Jul 13, 2010
Bis-aryl amide compounds and methods of use
AMGEN INC29 citations92
US7435823B2Oct 14, 2008
Compounds and methods of use
AMGEN INC19 citations92
US7776869B2Aug 17, 2010
Heteroaryl-substituted alkyne compounds and method of use
AMGEN INC20 citations91
US7442698B2Oct 28, 2008
Substituted heterocyclic compounds and methods of use
AMGEN INC11 citations83
MARTIN MATTHEW W
1 patentShowing the top 50 of 73 patents by PatentIndex Score.